WHWK — Whitehawk Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Whitehawk Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	149	173	109	47.2	146
Net Total Accounts Receivable
Net Total Receivables	—	1.86	5.49	5.9	0
Total Inventory
Prepaid Expenses
Total Current Assets	151	180	125	61.3	149
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.614	2.03	5.97	7.63	0.003
Net Intangible Assets
Other Long Term Assets
Total Assets	158	184	132	70.3	151
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	15.3	18.8	26.4	17.1	14.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.5	25.9	27.2	17.8	14.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	136	158	105	52.5	136
Total Liabilities & Shareholders' Equity	158	184	132	70.3	151
Total Common Shares Outstanding